166
Participants
Start Date
April 30, 2021
Primary Completion Date
June 4, 2022
Study Completion Date
September 10, 2023
Niclosamide
Niclosamide tablets 400 mg 3 times daily for 14 days
Placebo
Matched placebo tablets 400 mg 3 times daily for 14 days
Private Enterprise Private Manufacturing Company Acinus, Kropyvnytskyi
IACT Health - Roswell, Columbus
LCC Medical Reserach Institute, LLC, Miami
Miami Clinical Research, Miami
University of South Florida, Tampa
Central Alabama Research, Birmingham
"Communal Non-Commercial Medical Enterprise Likarnya Prydniprovska", Kremenchuk
"Municipal Non-profit Enterprise City Clinical Hospital # 4 of Dnipro City Council", Dnipro
Yashoda Hospital, Secunderabad
Municipal Non-Profit Enterprise City Clinical Hospital 13 of Kharkiv Regional Council, Kharkiv
SMS Clinical Research LLC, Mesquite
Municipal Non-profit Enterprise Central City Clinical Hospital of Ivano-Frankivsk City Council, Ivano-Frankivsk
Tranquil Research, Webster
Snake River Research, PLLC, Idaho Falls
Sir Ganga Ram Hospital, Nagar
Maharaja Agrasen Superspeciality Hospital, Jaipur, Jaipur
SSG Hospital and Medical Institute, Vadodara
GMERS Medical College and Hospital, Vadodara
Noble Hospital Private Limited, Pune
Malla Reddy Narayana Multispecialty Hospital, Hyderabad
Midland Florida Clinical Research Center, LLC, DeLand
New Generation Medical Research, Hialeah
Westchester General Hospital, Miami
P & S Research, LLC, Miami
Homestead Associates in Research, Homestead Meadows
Lead Sponsor
Entero Therapeutics
INDUSTRY